4yr
Reduction in migraine pain intensity in patients treated with erenumab: A post hoc analysis of two pivotal randomized studies - PubMed
Source : https://pubmed.ncbi.nlm.nih.gov/34407654/
1 The Saul R. Korey Department of Neurology, Albert Einstein College of Medicine, Bronx, NY, USA. 2 Mayo Clinic, Phoenix, AZ, USA. 3 California Medical Clinic for Headache, Santa Monica, CA, USA. 4 Department of Neurology, Charité Universitätsmedizin Berlin, Berlin, Germany. 5 Novartis Pharma AG., Basel, Switzerland.
Erenumab reduced cumulative monthly migraine pain in episodic migraine and chronic migraine patients and significantly reduced monthly average migraine pain in episodic migraine, demonstrating treatment benefit beyond reduction in migraine frequency